Susceptibility of Pigs and Chickens to SARS Coronavirus

Emerging Infectious Diseases

Volumn 10, Issue 2, 2004, Pages 179-184

  Weingart, Hana M ^a,b   Copps, John ^a   Drebot, Michael A ^a   Marszal, Peter ^a   Smith, Greg ^a   Gren, Jason ^a   Andonova, Maya ^a   Pasick, John ^a   Kitching, Paul ^a   Czub, Markus ^a  

^a Canadian Science Centre for Human and Animal Health   (Canada)

^b NONE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS RNA;

ANIMAL CELL; ANIMAL MODEL; ANTIBODY DETECTION; ARTICLE; AUTOPSY; CHICKEN; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DOMESTIC ANIMAL; EPIDEMIC; HOST; INOCULATION; NONHUMAN; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARS CORONAVIRUS; SEVERE ACUTE RESPIRATORY SYNDROME; SWINE; VIRUS IDENTIFICATION; VIRUS ISOLATION;

EID: 10744225367     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1002.030677     Document Type: Article

References (11)

1. Marra MA, Jones SJM, Astell CR, Holt RA, Brooks-Wilson A, Butterfield YSN, et al. The genome sequence of the SARS-associated-CoV. Science 2003;300:1399-404.
2. Rota PA, Oberste MS, Monroe SS, Nix WA, Campagnoli R, Icenogle JP, et al. Characterization of a novel coronavirus associated with severe acute respiratory syndrome. Science 2003;300:1394-9.
3. Kuiken T, Fouchier RA, Schutten M, Rimmelzwaan GF, van Amerongen G, van Riel D, et al. Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome. Lancet 2003;362:263-70.
4. Cox E, Pensaert M, Hooyberghs J, Van Deun K. Sites of replication of porcine respiratory coronavirus in 5-week-old pigs with or without maternal antibodies. Adv Exp Med Biol 1990;276:429-33.
5. Beaty BJ, Calisher CH, Shope RS. Arboviruses. In: Schmidt NJ, Emmons RW, editors. Diagnostic procedures for viral, rickettsial and chlamydial infections. 6th ed. Washington: American Public Health Association; 1989. p. 797-856.
6. Lai MMC, Cavanagh D. The molecular biology of coronaviruses. Adv Virus Res 1997;48:1-100.
7. Sawicki SG, Sawicki DL. A new model for coronavirus transcription. Adv Exp Med Biol 1998;440:215-9.
8. Igarashi T, Brown C, Azadegan A, Haigwood N, Dimitrov D, Martin MA, et al. Human immunodeficiency virus type I neutralizing antibodies accelerate clearance of cell-free virions from blood plasma. Nat Med 1999;5:211-6.
9. Bernard KA, Klimstra WB, Johnston RE. Mutations of the E2 glycoprotein of Venezuelan equine encephalitis virus confer heparan sulfate interaction, low morbidity, and rapid clearance from blood of mice. Virology 2000;276:93-103.
10. Have P. Infection with a new porcine respiratory coronavirus in Denmark: serologic differentiation from transmissible gastroenteritis virus using monoclonal antibodies. Adv Exp Med Biol 1990;276:435-9.
11. Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Perct T, Emery S, et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003;348:1953-66